Eli Lilly cuts price of weight-loss drug Zepbound to take on copycats
Eli Lilly and Company cut the prices of its weight-loss drug Zepbound, available in single-dose vials, in a bid to end compounding companies from.
Drugs
Health
Pharma
Drugs
Health
Pharma
UK watchdog blocks AstraZeneca, Daiichi’s breast cancer drug
Daiichi Sankyo and AstraZeneca’s breast cancer treatment ran into opposition from the UK’s healthcare spending watchdog, which wants Enhertu drug to be offered.